{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "67-year-old male with a 25-pack-year smoking history presented with left focal motor seizure and expressive aphasia.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "67-year-old male presented with left focal motor seizure and expressive aphasia.",
              "onset": "sudden",
              "progression": "sudden",
              "associated_symptoms": [
                "C0003638",
                "C0003684"
              ]
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "25-pack-year smoking history"
            }
          ],
          "diagnoses": [
            {
              "code": "C0003638",
              "label": "Seizure",
              "status": "active"
            },
            {
              "code": "C0003684",
              "label": "Aphasia, Expressive",
              "status": "active"
            }
          ]
        }
      },
      "custom_id": "graph_045_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Brain MRI demonstrated innumerable supra- and infratentorial peripheral enhancing lesions with edema, suggesting intracranial metastases.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Brain MRI",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "innumerable supra- and infratentorial peripheral enhancing lesions with edema",
              "impression": "intracranial metastases"
            }
          ]
        }
      },
      "custom_id": "graph_045_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Body positron emission tomography-CT revealed a hypermetabolic left lung mass and mediastinal and supraclavicular lymph nodes compatible with lung cancer.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Positron emission tomography-CT",
              "body_part": "lung",
              "modality": "PET",
              "finding": "hypermetabolic left lung mass and mediastinal and supraclavicular lymph nodes",
              "impression": "compatible with lung cancer"
            }
          ],
          "diagnoses": [
            {
              "code": "C0024117",
              "label": "Lung Cancer",
              "status": "suspected"
            }
          ]
        }
      },
      "custom_id": "graph_045_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Endobronchial biopsy of the lung mass revealed adenocarcinoma. PDL1 IHC (22C3) was 100%. IHC testing for HER2 expression was 2+. FISH testing demonstrated HER2 amplification with an average HER2 copy number of > 4.0 signals per cell. Next-generation DNA-based sequencing testing later revealed a HER2 exon20 insertion, reported as \u201cERBB2 Y772_A775dup\u201d. Received prior platinum chemotherapy.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "PD-L1 IHC (22C3)",
              "value": "100%",
              "unit": "%",
              "flag": "unknown"
            },
            {
              "test": "HER2 expression",
              "value": "2+",
              "unit": null,
              "flag": "unknown"
            },
            {
              "test": "HER2 copy number",
              "value": "> 4.0",
              "unit": "signals per cell",
              "flag": "abnormal"
            },
            {
              "test": "ERBB2 Y772_A775dup",
              "value": "positive",
              "unit": null,
              "flag": "unknown"
            }
          ],
          "procedures": [
            {
              "name": "Endobronchial biopsy",
              "approach": "endoscopic",
              "date": null,
              "location": "lung mass",
              "performed_by": null,
              "outcome": null
            }
          ],
          "medications": [
            {
              "drug": "platinum chemotherapy",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "adenocarcinoma"
            }
          ]
        }
      },
      "custom_id": "graph_045_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Started pembrolizumab due to high PD-L1 expression. WBRT was recommended for brain metastases. Follow-up brain MRI identified significantly increased size and number (> 60) of brain metastases. Pembrolizumab was discontinued after 1 cycle.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C939153",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "imaging": [
            {
              "type": "C0006141",
              "body_part": "C0006271",
              "modality": "MRI",
              "finding": "increased size and number (> 60) of brain metastases",
              "impression": null,
              "date": null
            }
          ],
          "procedures": [
            {
              "name": "C1705156",
              "approach": null,
              "date": null,
              "location": "C0006271",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      },
      "custom_id": "graph_045_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "T-DXd 5.4 mg/kg was started. Bevacizumab 7.5 mg/kg was also initiated due to symptomatic corticosteroid-dependent cerebral edema.",
        "clinical_data": {
          "medications": [
            {
              "drug": "T-DXd",
              "dosage": "5.4 mg/kg",
              "frequency": "unknown",
              "modality": "IV",
              "start_date": "null",
              "end_date": "null",
              "indication": "unknown"
            },
            {
              "drug": "Bevacizumab",
              "dosage": "7.5 mg/kg",
              "frequency": "unknown",
              "modality": "IV",
              "start_date": "null",
              "end_date": "null",
              "indication": "Cerebral edema"
            }
          ]
        }
      },
      "custom_id": "graph_045_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Repeat MRI brain 6 weeks after T-DXd revealed remarkable improvement in cerebral edema and metastases. Repeat CT chest revealed a decrease in size of the previously noted spiculated left lower",
        "clinical_data": {
          "imaging": [
            {
              "type": "Magnetic resonance imaging of brain",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "remarkable improvement in cerebral edema and metastases",
              "date": null
            },
            {
              "type": "Computed tomography of chest",
              "body_part": "Chest",
              "modality": "CT",
              "finding": "decrease in size of the previously noted spiculated left lower",
              "date": null
            }
          ]
        }
      },
      "custom_id": "graph_045_N6"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient's condition progressed, and brain MRI was performed.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C0003638",
            "C0003684"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_045_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Further investigation with PET-CT to identify the primary cancer source.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_045_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Lung mass biopsy and further molecular testing were performed.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      },
      "custom_id": "graph_045_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Treatment initiated with pembrolizumab based on PD-L1 expression, followed by WBRT recommendation. However, brain metastases worsened, leading to pembrolizumab discontinuation.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C939153"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_045_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Treatment changed to T-DXd and bevacizumab due to disease progression and cerebral edema.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "T-DXd",
            "Bevacizumab"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_045_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Follow-up imaging showed improvement in cerebral edema, metastases, and lung mass size after T-DXd treatment.",
        "transition_event": {
          "trigger_type": "imaging",
          "trigger_entities": [],
          "change_type": "resolution",
          "target_domain": "imaging"
        }
      },
      "custom_id": "graph_045_N6_N7"
    }
  ]
}